BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1990612)

  • 1. The effect of xenoantibody and formed cellular blood elements on ex vivo xenograft hyperacute rejection.
    Han LK; Henry ML; Ferguson RM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):574-5. PubMed ID: 1990612
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of xenograft hyperacute rejection via xenoantibody depletion.
    Henry ML; Han LK; Orosz CG; Sedmak D; Ferguson RM
    Transplant Proc; 1990 Jun; 22(3):1081-2. PubMed ID: 2349665
    [No Abstract]   [Full Text] [Related]  

  • 3. Modification of hyperactive xenograft rejection by ex vivo xenoantibody adsorption.
    Han LK; Henry ML; Orosz CG; Sedmak DD; Ferguson RM
    Curr Surg; 1990; 47(1):15-7. PubMed ID: 2178879
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal xenografts perfused ex vivo require both humoral and cellular components to undergo hyperacute rejection.
    Bryan BA; Henry ML; Ferguson RM
    Transplant Proc; 1992 Apr; 24(2):609. PubMed ID: 1566449
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of a PAF-antagonist (WEB 2086) on hyperacute xenogeneic rejection in ex vivo perfused kidneys.
    Bergmann R; Saumweber DM; Brecht HM; Hammer C
    Transplant Proc; 1990 Aug; 22(4):2009-10. PubMed ID: 2389511
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperacute rejection in an ex vivo model of renal xenografting. Role of the mediator response and its pharmacologic manipulation by the specific platelet-activating factor antagonist WEB 2086BS.
    Saumweber DM; Bergmann R; Gokel M; Hammer C
    Transplantation; 1994 Feb; 57(3):358-63. PubMed ID: 8108870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin in the pig-to-human combination.
    Gautreau C; Cardoso J; Woimant G; Zhao Z; Chereau C; Cherruau B; Vandeginste N; Devillier P; Houssin D
    Transplant Proc; 1994 Jun; 26(3):1281. PubMed ID: 8029908
    [No Abstract]   [Full Text] [Related]  

  • 8. Xenotransplantation from pig to cynomolgus monkey: the potential for overcoming xenograft rejection through induction of chimerism.
    Tanaka M; Latinne D; Gianello P; Sablinski T; Lorf T; Bailin M; Nickeleit V; Colvin R; Lebowitz E; Sykes M
    Transplant Proc; 1994 Jun; 26(3):1326-7. PubMed ID: 8029926
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo and in vitro study of hyperacute rejection mechanism of renal discordant xenograft.
    Marino IR; Ferla G; Celli S; Stieber A; Muttillo I; Maggiano N; Perrelli L; Musiani P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):620-2. PubMed ID: 1990627
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperacute rejection of renal discordant xenograft (pig-to-rabbit): model assessment and rejection mechanisms.
    Marino IR; Ferla G; Celli S; Stieber A; Muttillo I; Maggiano N; Mazzaferro V; Perrelli L; Musiani P
    Transplant Proc; 1990 Jun; 22(3):1071-6. PubMed ID: 2190372
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathology of renal xenograft rejection in pig to non-human primate transplantation.
    Shimizu A; Yamada K
    Clin Transplant; 2006; 20 Suppl 15():46-52. PubMed ID: 16848876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of hyperacute xenograft rejection in unmodified host by extracorporeal plasma perfusion.
    Yoshioka H; McCalmon RT; Putnam CW; McIntosh RM; Terman DS
    Transplantation; 1977 Jul; 24(1):78-81. PubMed ID: 329497
    [No Abstract]   [Full Text] [Related]  

  • 13. Discordant xenogeneic cellular interactions when hyperacute rejection is prevented: analysis using an ex vivo model of pig kidney perfused with human lymphocytes.
    Khalfoun B; Janin P; Machet MC; Lacord M; Riess G; Salmon H; Nivet H; Gruel Y; Bardos P; Lebranchu Y
    Transplant Proc; 1996 Apr; 28(2):647. PubMed ID: 8623322
    [No Abstract]   [Full Text] [Related]  

  • 14. Nitric oxide and endothelins are effector agents of hyperacute vascular rejection.
    Castillo J; Berrazueta JR; Herrera L; de Vega MJ; Val JF; Amado JA; Gómez J; Gómez-Fleitas M
    Transplant Proc; 1996 Apr; 28(2):635. PubMed ID: 8623316
    [No Abstract]   [Full Text] [Related]  

  • 15. Ex vivo spleen and kidney absorption of xenoreactive natural antibodies decreases severity of hyperacute rejection in pig-to-dog renal xenotransplantation.
    Nitta K
    Hiroshima J Med Sci; 1996 Dec; 45(4):119-25. PubMed ID: 9119710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte inhibition and ex vivo whole blood xenoperfusion.
    Henry ML; Bendle MD; Ferguson RM
    Transplant Proc; 1994 Jun; 26(3):1311. PubMed ID: 8029919
    [No Abstract]   [Full Text] [Related]  

  • 17. Human plasma causes rapid dysfunction in ex vivo pig hearts.
    Robbins RC; Mitchell ME; Sachs DH; Clark RE
    J Heart Lung Transplant; 1994; 13(5):877-81. PubMed ID: 7803431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperacute xenograft rejection as an immunologic barrier to xenotransplantation.
    Daniels LJ; Platt JL
    Kidney Int Suppl; 1997 Mar; 58():S28-35. PubMed ID: 9067939
    [No Abstract]   [Full Text] [Related]  

  • 19. Ex vivo model for xenotransplantation.
    Fiane AE; Videm V; Scholz T; Pedersen T; Karlsen H; Geiran O; Foerster A; Mollnes T; Aasen AO; Svennevig J
    Transplant Proc; 1995 Dec; 27(6):3560-1. PubMed ID: 8540102
    [No Abstract]   [Full Text] [Related]  

  • 20. [Elimination of natural antibodies in discordant xenografts].
    Gianello P
    Pathol Biol (Paris); 1994 Mar; 42(3):225-9. PubMed ID: 8090571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.